神经可塑性、迷幻疗法及人工智能驱动的精准医学创新的综合进展
Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine.
作者信息
Kargbo Robert B
机构信息
Usona Institute, Fitchburg, Wisconsin 53711-5300, United States.
出版信息
ACS Med Chem Lett. 2025 Mar 6;16(4):520-522. doi: 10.1021/acsmedchemlett.5c00112. eCollection 2025 Apr 10.
Recent advancements in psychedelic therapeutics, tryptamine derivatives, neuroplastic modulators, and AI-powered machine-learning platforms mark a new frontier in precision medicine. These innovations address critical challenges in neurological and psychiatric disorders, chronic pain management, and computational accessibility. By harnessing the principles of receptor modulation, targeted delivery systems, and simplified AI integration, these breakthroughs promise transformative solutions for patient care and technological development.
迷幻疗法、色胺衍生物、神经可塑性调节剂和人工智能驱动的机器学习平台的最新进展标志着精准医学的一个新前沿。这些创新解决了神经和精神疾病、慢性疼痛管理以及计算可及性方面的关键挑战。通过利用受体调节、靶向递送系统和简化的人工智能整合原则，这些突破有望为患者护理和技术发展带来变革性解决方案。
Zotero 插件